Bernard De Bruyne

Bernard De Bruyne's AcademicInfluence.com Rankings

Bernard De Bruyne

Philosophy

#5852

World Rank

#8772

Historical Rank

Logic

#3062

World Rank

#4166

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Bernard De Bruyne's Degrees

Doctorate Medicine KU Leuven

Why Is Bernard De Bruyne Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Bernard De Bruyne's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. (2009) (2821)
A prospective natural-history study of coronary atherosclerosis. (2011) (2643)
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. (2012) (2127)
Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. (1996) (2044)
Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. (2007) (1440)
Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). (2014) (1122)
Experimental Basis of Determining Maximum Coronary, Myocardial, and Collateral Blood Flow by Pressure Measurements for Assessing Functional Stenosis Severity Before and After Percutaneous Transluminal Coronary Angioplasty (1993) (1097)
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. (2010) (1043)
Fractional flow reserve-guided PCI for stable coronary artery disease. (2014) (867)
Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis: A Randomized Trial (2001) (826)
Relation between myocardial blood flow and the severity of coronary-artery stenosis. (1994) (660)
Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. (2010) (555)
Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. (2006) (515)
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. (2010) (506)
Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. (2014) (501)
Intracoronary Injection of CD133-Positive Enriched Bone Marrow Progenitor Cells Promotes Cardiac Recovery After Recent Myocardial Infarction: Feasibility and Safety (2005) (500)
Simultaneous coronary pressure and flow velocity measurements in humans. Feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve. (1996) (494)
Five‐Year Outcomes with PCI Guided by Fractional Flow Reserve (2018) (485)
Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. (1994) (479)
Abnormal Epicardial Coronary Resistance in Patients With Diffuse Atherosclerosis but “Normal” Coronary Angiography (2001) (468)
Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFRCT: outcome and resource impacts study (2015) (464)
Improvement of Left Ventricular Function After Cardiac Resynchronization Therapy Is Predicted by Tissue Doppler Imaging Echocardiography (2004) (448)
One year follow-up of the multi-centre European PARTNER transcatheter heart valve study (2010) (416)
Long-Term Clinical Outcome After Fractional Flow Reserve–Guided Treatment in Patients With Angiographically Equivocal Left Main Coronary Artery Stenosis (2009) (373)
Fractional Flow Reserve in Patients With Prior Myocardial Infarction (2001) (370)
Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. (2015) (360)
Economic Evaluation of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease (2010) (358)
Intracoronary and Intravenous Adenosine 5′-Triphosphate, Adenosine, Papaverine, and Contrast Medium to Assess Fractional Flow Reserve in Humans (2003) (351)
Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis: Six-Month Clinical and Imaging Outcomes (2010) (336)
Coronary Thermodilution to Assess Flow Reserve: Validation in Humans (2002) (312)
Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. (1995) (310)
Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. (2007) (308)
Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe). (1997) (303)
Coronary Pressure Measurement After Stenting Predicts Adverse Events at Follow-Up: A Multicenter Registry (2002) (301)
Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting Pd/Pa with fractional flow reserve: the RESOLVE study. (2014) (293)
Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. (2010) (286)
1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease: The PLATFORM Study. (2016) (281)
Coronary Pressure Measurement to Assess the Hemodynamic Significance of Serial Stenoses Within One Coronary Artery: Validation in Humans (2000) (275)
Coronary Thermodilution to Assess Flow Reserve: Experimental Validation (2001) (262)
Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses. (2014) (254)
Assessment of renal artery stenosis severity by pressure gradient measurements. (2006) (251)
Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. (2012) (249)
Pressure-derived fractional flow reserve to assess serial epicardial stenoses: theoretical basis and animal validation. (2000) (244)
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. (2014) (244)
Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease. (2010) (240)
5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. (2010) (240)
Epicardial Stenosis Severity Does Not Affect Minimal Microcirculatory Resistance (2004) (239)
Quantification of recruitable coronary collateral blood flow in conscious humans and its potential to predict future ischemic events. (1995) (238)
Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. (2011) (233)
Functional SYNTAX score for risk assessment in multivessel coronary artery disease. (2011) (228)
VERIFY (VERification of Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Coronary Artery Stenosis Severity in EverydaY Practice): a multicenter study in consecutive patients. (2013) (212)
Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement. (1998) (211)
First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold: A Multi-Imaging Modality Study (2012) (204)
Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. (2005) (193)
Early- and long-term intravascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human coronary arteries. (2009) (192)
Safety and Effectiveness of Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses: The Disrupt CAD II Study. (2019) (192)
Value of fractional flow reserve in making decisions about bypass surgery for equivocal left main coronary artery disease (2001) (190)
Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. (2005) (189)
Noninvasive Fractional Flow Reserve Derived From Coronary CT Angiography: Clinical Data and Scientific Principles. (2015) (189)
From research to clinical practice: current role of intracoronary physiologically based decision making in the cardiac catheterization laboratory. (1997) (186)
Transstenotic coronary pressure gradient measurement in humans: in vitro and in vivo evaluation of a new pressure monitoring angioplasty guide wire. (1993) (184)
Effect of aging on myocardial perfusion reserve. (1995) (178)
Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: lessons from the ADVANCE Registry (2018) (177)
Practice and potential pitfalls of coronary pressure measurement (2000) (171)
Fractional flow reserve: a review (2008) (168)
Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. (2004) (168)
Fractional Flow Reserve–Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery (2013) (167)
Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation. (2020) (165)
Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. (2008) (163)
Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation. (2020) (161)
1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT: The ADVANCE Registry. (2020) (161)
Identification of High-Risk Plaques Destined to Cause Acute Coronary Syndrome Using Coronary Computed Tomographic Angiography and Computational Fluid Dynamics. (2019) (159)
Comparison of in vivo acute stent recoil between the bioabsorbable everolimus‐eluting coronary stent and the everolimus‐eluting cobalt chromium coronary stent: Insights from the ABSORB and SPIRIT trials (2007) (157)
Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty. (1999) (157)
Microvascular Resistance Is Not Influenced by Epicardial Coronary Artery Stenosis Severity: Experimental Validation (2004) (153)
Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study. (2011) (152)
A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up. (2016) (150)
Quality-of-Life and Economic Outcomes of Assessing Fractional Flow Reserve With Computed Tomography Angiography: PLATFORM. (2015) (145)
Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? (2012) (143)
Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation). (2017) (142)
Validation of coronary flow reserve measurements by thermodilution in clinical practice. (2004) (142)
Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. (2007) (140)
Quantitative coronary angiography in predicting functional significance of stenoses in an unselected patient cohort. (1995) (136)
Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data (2018) (135)
Comparison of Different Diastolic Resting Indexes to iFR: Are They All Equal? (2017) (134)
Direct volumetric blood flow measurement in coronary arteries by thermodilution. (2007) (132)
Standardization of Fractional Flow Reserve Measurements. (2016) (132)
Revascularization Decisions in Patients With Stable Angina and Intermediate Lesions: Results of the International Survey on Interventional Strategy (2014) (129)
Continuum of Vasodilator Stress From Rest to Contrast Medium to Adenosine Hyperemia for Fractional Flow Reserve Assessment. (2016) (125)
Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes. (2012) (123)
Randomized Comparison of Primary Stenting and Provisional Balloon Angioplasty Guided by Flow Velocity Measurement (2000) (123)
Validation of a novel non-hyperaemic index of coronary artery stenosis severity: the Resting Full-cycle Ratio (VALIDATE RFR) study. (2018) (122)
Accuracy of Fractional Flow Reserve Derived From Coronary Angiography (2019) (121)
Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation (2017) (118)
Long-Term Patency of Internal Mammary Artery Bypass Grafts: Relationship With Preoperative Severity of the Native Coronary Artery Stenosis (2004) (117)
Translesional Pressure Gradients to Predict Blood Pressure Response After Renal Artery Stenting in Patients With Renovascular Hypertension (2010) (115)
A Prospective Natural History Study of Coronary Atherosclerosis Using Fractional Flow Reserve. (2016) (114)
Coronary pressure measurement and fractional flow reserve (1998) (113)
Transcatheter valve-in-ring implantation after failure of surgical mitral repair. (2013) (111)
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Ev (2014) (111)
A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents. (2010) (110)
Comparison of in vivo acute stent recoil between the bioresorbable everolimus‐eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus‐eluting stent (2011) (109)
Significance of Intermediate Values of Fractional Flow Reserve in Patients With Coronary Artery Disease (2016) (107)
Dobutamine-induced wall motion abnormalities: correlations with myocardial fractional flow reserve and quantitative coronary angiography. (1996) (104)
Stent Placement to Prevent Restenosis After Angioplasty in Small Coronary Arteries (2001) (104)
Intracoronary Adenosine: Dose-Response Relationship With Hyperemia. (2015) (102)
Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) study. (2007) (101)
Diagnostic performance of angiography-derived fractional flow reserve: a systematic review and Bayesian meta-analysis (2018) (100)
Prevalence, Distribution, Predictors, and Outcomes of Patients With Calcified Nodules in Native Coronary Arteries: A 3-Vessel Intravascular Ultrasound Analysis From Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT) (2012) (100)
High Coronary Shear Stress in Patients With Coronary Artery Disease Predicts Myocardial Infarction. (2018) (99)
Interference of Drug-Eluting Stents With Endothelium-Dependent Coronary Vasomotion: Evidence for Device-Specific Responses (2008) (98)
On the inappropriateness of noninvasive multidetector computed tomography coronary angiography to trigger coronary revascularization: a comparison with invasive angiography. (2009) (97)
Does the instantaneous wave-free ratio approximate the fractional flow reserve? (2013) (96)
Long-term follow-up after fractional flow reserve-guided treatment strategy in patients with an isolated proximal left anterior descending coronary artery stenosis. (2011) (95)
Measurement of Hyperemic Pullback Pressure Gradients to Characterize Patterns of Coronary Atherosclerosis. (2019) (93)
Assessment of renal artery stenosis: side-by-side comparison of angiography and duplex ultrasound with pressure gradient measurements. (2008) (92)
A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study. (2012) (91)
Comparison of exercise electrocardiography and dobutamine echocardiography with invasively assessed myocardial fractional flow reserve in evaluation of severity of coronary arterial narrowing. (1997) (91)
Cost-Effectiveness of Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease and Abnormal Fractional Flow Reserve (2013) (89)
Intracoronary delivery of hematopoietic bone marrow stem cells and luminal loss of the infarct-related artery in patients with recent myocardial infarction. (2006) (89)
Virtual histology intravascular ultrasound analysis of non-culprit attenuated plaques detected by grayscale intravascular ultrasound in patients with acute coronary syndromes. (2010) (88)
Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction. (2021) (87)
Fractional Flow Reserve Assessment of Left Main Stenosis in the Presence of Downstream Coronary Stenoses (2012) (87)
Effects of dobutamine on coronary stenosis physiology and morphology: comparison with intracoronary adenosine. (1999) (87)
Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial (2012) (84)
Lesion-Specific and Vessel-Related Determinants of Fractional Flow Reserve Beyond Coronary Artery Stenosis. (2018) (83)
Repeatability of Fractional Flow Reserve Despite Variations in Systemic and Coronary Hemodynamics. (2015) (82)
Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation. (2008) (81)
The impact of downstream coronary stenosis on fractional flow reserve assessment of intermediate left main coronary artery disease: human validation. (2015) (81)
Clinical value of post–percutaneous coronary intervention fractional flow reserve value: A systematic review and meta‐analysis (2017) (80)
Abnormal systolic intraventricular flow velocities after valve replacement for aortic stenosis. Mechanisms, predictive factors, and prognostic significance. (1996) (80)
Severe left ventricular dyssynchrony is associated with poor prognosis in patients with moderate systolic heart failure undergoing coronary artery bypass grafting. (2007) (79)
The impact of sex differences on fractional flow reserve-guided percutaneous coronary intervention: a FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) substudy. (2012) (79)
The Prognostic Value of Residual Coronary Stenoses After Functionally Complete Revascularization. (2016) (78)
Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery. (2021) (78)
Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study. (2012) (76)
Severity of coronary arterial stenoses responsible for acute coronary syndromes. (2009) (76)
Catheter-Based Measurements of Absolute Coronary Blood Flow and Microvascular Resistance: Feasibility, Safety, and Reproducibility in Humans (2018) (75)
Computational fluid dynamic measures of wall shear stress are related to coronary lesion characteristics (2016) (74)
Definitions and methodology for the grayscale and radiofrequency intravascular ultrasound and coronary angiographic analyses. (2012) (74)
Longitudinal distribution of plaque burden and necrotic core-rich plaques in nonculprit lesions of patients presenting with acute coronary syndromes. (2012) (73)
Long-Term Clinical Outcome After Fractional Flow Reserve–Guided Percutaneous Coronary Revascularization in Patients With Small-Vessel Disease (2012) (72)
The Influence of Lesion Location on the Diagnostic Accuracy of Adenosine-Free Coronary Pressure Wire Measurements. (2016) (72)
High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention. (2010) (71)
Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris. (2008) (70)
The impact of downstream coronary stenoses on fractional flow reserve assessment of intermediate left main disease. (2012) (70)
Percutaneous coronary intervention of bifurcation lesions: state-of-the-art. Insights from the second meeting of the European Bifurcation Club. (2007) (69)
Noninvasive prediction of pulmonary hypertension in chronic obstructive pulmonary disease by Doppler echocardiography. (1987) (67)
Quantitative assessment of coronary microvascular function in patients with and without epicardial atherosclerosis. (2010) (67)
Early and late effects of cardiac resynchronization therapy on force-frequency relation and contractility regulating gene expression in heart failure patients. (2008) (67)
Validation Study of Image-Based Fractional Flow Reserve During Coronary Angiography (2017) (66)
Role of &bgr;2 Adrenergic Receptors in Human Atherosclerotic Coronary Arteries (2005) (65)
Frequency of abdominal aortic aneurysm in patients >60 years of age with coronary artery disease. (2005) (63)
Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance. (2007) (63)
Six-Year Follow-Up of Fractional Flow Reserve-Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery (2018) (63)
Clinical and angiographic outcome of elective stent implantation in small coronary vessels: an analysis of the BENESTENT trial. (1996) (63)
Myocardial perfusion and oxygen consumption in reperfused noninfarcted dysfunctional myocardium after unstable angina: direct evidence for myocardial stunning in humans. (1999) (62)
Effect of the ratio of coronary arterial lumen volume to left ventricle myocardial mass derived from coronary CT angiography on fractional flow reserve. (2017) (61)
Myocardial resistance assessed by guidewire‐based pressure‐temperature measurement: In vitro validation (2004) (61)
Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. (2001) (61)
Novel monorail infusion catheter for volumetric coronary blood flow measurement in humans: in vitro validation. (2016) (61)
Clinical Outcomes Following Coronary Bifurcation PCI Techniques: A Systematic Review and Network Meta-Analysis Comprising 5,711 Patients. (2020) (60)
Coronary Flow Velocity Reserve After Percutaneous Interventions Is Predictive of Periprocedural Outcome (2002) (60)
Potential protective effect of high coronary wedge pressure on left ventricular function after coronary occlusion. (1988) (57)
Hybrid Revascularization Strategy: A Pilot Study on the Association of Robotically Enhanced Minimally Invasive Direct Coronary Artery Bypass Surgery and Fractional Flow Reserve-Guided Percutaneous Coronary Intervention (2005) (57)
Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease. (2015) (57)
Comparative Effects of Pacing‐Induced and Balloon Coronary Occlusion Ischemia on Left Ventricular Diastolic Function in Man (1991) (57)
A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial. (2012) (57)
Comparative Effects of Ischemia and Hypoxemia on Left Ventricular Systolic and Diastolic Function in Humans (1993) (56)
Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments. (2012) (56)
Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study. Fraxiparine Angioplastie Coronaire Transluminale. (1997) (53)
Assessment of renal flow and flow reserve in humans. (2006) (53)
Coronary wedge pressure: a predictor of restenosis after coronary balloon angioplasty. (1987) (52)
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up. (2011) (51)
Angiographical and Doppler flow-derived parameters for assessment of coronary lesion severity and its relation to the result of exercise electrocardiography. DEBATE study group. Doppler Endpoints Balloon Angioplasty Trial Europe. (2000) (50)
Three-year follow-up of the ARTS-II# - sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. (2008) (50)
Non-fibroatheroma lesion phenotype and long-term clinical outcomes: a substudy analysis from the PROSPECT study. (2013) (50)
Intracoronary EnalaPrilat to Reduce MICROvascular Damage During Percutaneous Coronary Intervention (ProMicro) study. (2013) (49)
Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: Insights from the ABSORB and SPIRIT trials (2011) (49)
Long-term clinical outcome after fractional flow reserve- versus angio-guided percutaneous coronary intervention in patients with intermediate stenosis of coronary artery bypass grafts. (2013) (49)
A simple thermodilution technique to assess coronary endothelium-dependent microvascular function in humans: validation and comparison with coronary flow reserve. (2007) (48)
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm. (2011) (47)
Impact of positive and negative lesion site remodeling on clinical outcomes: insights from PROSPECT. (2014) (47)
Impact of Right Atrial Pressure on Fractional Flow Reserve Measurements: Comparison of Fractional Flow Reserve and Myocardial Fractional Flow Reserve in 1,600 Coronary Stenoses. (2016) (47)
Effective radiation dose, time, and contrast medium to measure fractional flow reserve. (2010) (47)
A prospective hemodynamic evaluation of patients with chronic atrial fibrillation undergoing radiofrequency catheter ablation of the atrioventricular junction. (1997) (46)
Angiography Versus Hemodynamics to Predict the Natural History of Coronary Stenoses: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation 2 Substudy. (2018) (46)
The impact of age on fractional flow reserve-guided percutaneous coronary intervention: a FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) trial substudy. (2014) (45)
Doppler assessment of left ventricular diastolic filling during brief coronary occlusion. (1989) (45)
Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting. The GRAFFITI trial. (2019) (44)
Angiographic follow-up after multivessel percutaneous transluminal coronary angioplasty. (1987) (44)
Effects of intravenous dobutamine on coronary vasomotion in humans. (2003) (44)
Validation of functional state of coronary tandem lesions using computational flow dynamics. (2012) (43)
Saline-Induced Coronary Hyperemia: Mechanisms and Effects on Left Ventricular Function (2017) (43)
Interpreting results of coronary computed tomography angiography-derived fractional flow reserve in clinical practice. (2017) (43)
Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention. (2012) (42)
Cardiac tamponade early after thrombolysis for acute myocardial infarction: a rare but not reported hemorrhagic complication. (1991) (41)
Quantitative angiography and optical coherence tomography for the functional assessment of nonobstructive coronary stenoses: comparison with fractional flow reserve. (2013) (41)
Accuracy of Fractional Flow Reserve Measurements in Clinical Practice: Observations From a Core Laboratory Analysis. (2017) (40)
Endomyocardial upregulation of beta1 adrenoreceptor gene expression and myocardial contractile reserve following cardiac resynchronization therapy. (2008) (39)
Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease. (2012) (39)
Predictive factors of discordance between the instantaneous wave‐free ratio and fractional flow reserve (2019) (38)
Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial. (2012) (38)
Effect of mitral valve repair on exercise tolerance in asymptomatic patients with organic mitral regurgitation. (2007) (38)
Time-Dependent Effects on Coronary Remodeling and Epicardial Conductance after Intracoronary Injection of Enriched Hematopoietic Bone Marrow Stem Cells in Patients with Previous Myocardial Infarction (2007) (38)
Association of Improvement in Fractional Flow Reserve With Outcomes, Including Symptomatic Relief, After Percutaneous Coronary Intervention (2019) (38)
Agreement of the Resting Distal to Aortic Coronary Pressure With the Instantaneous Wave-Free Ratio. (2017) (38)
Rationale and application of coronary transstenotic pressure gradient measurements. (1994) (38)
Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment. (2013) (38)
Pressure-derived measurement of coronary flow reserve. (2005) (37)
Dynamic left ventricular outflow tract obstruction after anterior myocardial infarction. A potential mechanism of myocardial rupture. (1995) (36)
Physiological Predictors of Acute Coronary Syndromes: Emerging Insights From the Plaque to the Vulnerable Patient. (2017) (36)
Comparison of 600 versus 300-mg Clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty. (2010) (36)
The pathophysiology and clinical course of the normal coronary angina syndrome (cardiac syndrome X). (2008) (36)
Impact of chronic kidney disease on platelet reactivity and outcomes of patients receiving clopidogrel and undergoing percutaneous coronary intervention. (2014) (35)
Fractional Flow Reserve-Guided Revascularization in Patients With Aortic Stenosis. (2016) (35)
Rationale, design and goals of the HeartFlow assessing diagnostic value of non-invasive FFRCT in Coronary Care (ADVANCE) registry. (2017) (35)
Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS. (2018) (34)
Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process. (2012) (34)
Periprocedural variations of platelet reactivity during elective percutaneous coronary intervention (2012) (34)
Visual and Quantitative Assessment of Coronary Stenoses at Angiography Versus Fractional Flow Reserve: The Impact of Risk Factors (2017) (34)
Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II) (2009) (33)
Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention. (2010) (33)
Fractional Flow Reserve Derived From Routine Coronary Angiograms. (2016) (33)
Thrombus aspiration in primary percutaneous coronary intervention in high‐risk patients with ST‐elevation myocardial infarction: A real‐world registry (2010) (32)
Tissue doppler imaging predicts recovery of left ventricular function after recanalization of an occluded coronary artery. (2004) (31)
Baseline fractional flow reserve and stent diameter predict optimal post-stent fractional flow reserve and major adverse cardiac events after bare-metal stent deployment. (2009) (31)
Comparison of drug-eluting versus bare-metal stents after rotational atherectomy for the treatment of calcified coronary lesions. (2012) (31)
Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting. (2011) (30)
Impact of TCFA on Unanticipated Ischemic Events in Medically Treated Diabetes Mellitus: Insights From the PROSPECT Study. (2017) (30)
Predictors of Plaque Rupture Within Nonculprit Fibroatheromas in Patients With Acute Coronary Syndromes: The PROSPECT Study. (2015) (29)
Incidence and predictors of lesion-specific ischemia by FFRCT: Learnings from the international ADVANCE registry. (2018) (29)
Improving the quality of percutaneous revascularisation in patients with multivessel disease in Australia: cost-effectiveness, public health implications, and budget impact of FFR-guided PCI. (2014) (28)
Microvascular Resistance Reserve for Assessment of Coronary Microvascular Function: JACC Technology Corner. (2021) (28)
Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents: a subanalysis of the ARTS II trial. (2007) (28)
Microvascular (Dys)Function and Clinical Outcome in Stable Coronary Disease. (2016) (27)
ACEF and clinical SYNTAX score in the risk stratification of patients with heavily calcified coronary stenosis undergoing rotational atherectomy with stent implantation (2014) (27)
Fractional flow reserve--the influence of the collateral circulation. (2009) (27)
In vitro and in vivo studies on thermistor‐based intracoronary temperature measurements: Effect of pressure and flow (2009) (27)
The age, creatinine, and ejection fraction score to risk stratify patients who underwent percutaneous coronary intervention of coronary chronic total occlusion. (2014) (27)
Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound. (2010) (26)
Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses. (2004) (26)
Non-invasive assessment of coronary flow reserve in idiopathic dilated cardiomyopathy: hemodynamic correlations. (2005) (26)
Role of side holes in guide catheters: observations on coronary pressure and flow. (1994) (25)
Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve (2021) (25)
Fractional flow reserve: concepts, applications and use in France in 2010. (2010) (25)
Periprocedural Myocardial Injury and Long-Term Clinical Outcome in Patients Undergoing Percutaneous Coronary Interventions of Coronary Chronic Total Occlusion. (2016) (25)
Thr164Ile polymorphism of β2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy (2007) (25)
Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. (2010) (25)
Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularization. (2007) (25)
Human coronary atherosclerosis modulates cardiac natriuretic peptide release. (2009) (25)
GLU-27 variant of beta2-adrenergic receptor polymorphisms is an independent risk factor for coronary atherosclerotic disease. (2007) (24)
Fractional flow reserve to guide and to assess coronary artery bypass grafting (2016) (24)
Uncomplicated moderate coronary artery dissections after balloon angioplasty: good outcome without stenting (2001) (24)
Normal Values of Thermodilution-Derived Absolute Coronary Blood Flow and Microvascular Resistance in Humans. (2020) (24)
Multislice computed tomography angiography for noninvasive assessment of the 18-month performance of a novel radiolucent bioresorbable vascular scaffolding device: the ABSORB trial (a clinical evaluation of the bioabsorbable everolimus eluting coronary stent system in the treatment of patients with (2013) (23)
Relationship of asymmetric dimethylarginine (ADMA) with extent and functional severity of coronary atherosclerosis. (2016) (23)
Characteristics and clinical significance of angiographically mild lesions in acute coronary syndromes. (2012) (23)
Adverse cardiovascular events arising from atherosclerotic lesions with and without angiographic disease progression. (2012) (23)
Serial in vivo intravascular ultrasound-based echogenicity changes of everolimus-eluting bioresorbable vascular scaffold during the first 12 months after implantation insights from the ABSORB B trial. (2011) (23)
Can Functional Testing for Ischemia and Viability Guide Revascularization? (2017) (23)
FFRCT and CT perfusion: A review on the evaluation of functional impact of coronary artery stenosis by cardiac CT. (2020) (23)
Hyperdynamic myocardial response to beta-adrenergic stimulation in patients with chest pain and normal coronary arteries. (2005) (22)
Five-year haemodynamic outcomes of the first-generation SAPIEN balloon-expandable transcatheter heart valve. (2016) (22)
Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: insights from ARTS I and ARTS II. (2009) (22)
Clinical assessment of functional stenosis severity: use of coronary pressure measurements for the decision to bypass a lesion. (1997) (22)
Relationship between palpography and virtual histology in patients with acute coronary syndromes. (2012) (22)
Diagnostic Performance of Angiogram-Derived Fractional Flow Reserve: A Pooled Analysis of 5 Prospective Cohort Studies. (2020) (20)
Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta‐Analysis (2022) (20)
Titanium-Nitride-Oxide-Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome: The Randomized TIDES-ACS Trial. (2020) (20)
Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease. (2013) (19)
Left internal mammary artery bypass dysfunction after revascularization of moderately narrowed coronary lesions. Colour-duplex ultrasound versus angiography study. (2007) (19)
Correlation between Angiographic and Physiologic Evaluation of Coronary Artery Narrowings in Patients With Aortic Valve Stenosis. (2017) (19)
The accordion phenomenon (2005) (19)
Relevance of anatomical, plaque, and hemodynamic characteristics of non-obstructive coronary lesions in the prediction of risk for acute coronary syndrome (2019) (18)
Images in cardiovascular medicine. The accordion phenomenon: lesson from a movie. (2008) (18)
Basics of Coronary Thermodilution. (2021) (18)
Fractional Flow Reserve and Quality-of-Life Improvement After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease (2018) (18)
Thresholds for platelet reactivity to predict clinical events after coronary intervention are different in patients with and without diabetes mellitus (2014) (18)
Thermodilution-Derived Volumetric Resting Coronary Blood Flow Measurement in Humans. (2021) (18)
Percutaneous transluminal coronary angioplasty catheters versus fluid-filled pressure monitoring guidewires for coronary pressure measurements and correlation with quantitative coronary angiography. (1993) (18)
One year results of a new in situ length-adjustable stent platform with a biodegradable biolimus A9 eluting polymer: results of the CUSTOM-II trial. (2008) (18)
Effect of phentolamine on the hyperemic response to adenosine in patients with microvascular disease. (2005) (17)
The recurrence of iatrogenic femoral artery pseudoaneurysm after occlusion by ultrasound guided percutaneous thrombin injection. (2009) (17)
Long-term clinical outcome of titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome: Final report of the BASE ACS trial. (2016) (17)
Fractional Flow Reserve in Acute Coronary Syndromes. (2016) (16)
Hemodynamic effects of inducible nitric oxide synthase and nitrotyrosine generation in heart failure. (2004) (16)
Practical tips and tricks for the measurement of fractional flow reserve (2010) (16)
Reducing operative mortality in valvular reoperations: the "valve in ring" procedure. (2011) (16)
High cholesterol levels are associated with coronary microvascular dysfunction (2012) (16)
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study. (2011) (16)
Fractional flow reserve: an indispensable diagnostic tool in the cardiac catheterisation laboratory. (2010) (15)
Transcriptional fingerprint of human whole blood at the site of coronary occlusion in acute myocardial infarction. (2011) (15)
Single String Technique for Coronary Bifurcation Stenting: Detailed Technical Evaluation and Feasibility Analysis. (2015) (15)
Rationale and design of the Prospective LongitudinAl Trial of FFRCT: Outcome and Resource IMpacts study. (2015) (15)
An intravascular ultrasound appraisal of atherosclerotic plaque distribution in diseased coronary arteries. (2012) (15)
Effects of Prasugrel Versus Clopidogrel on Coronary Microvascular Function in Patients Undergoing Elective PCI. (2016) (15)
Midterm clinical outcome following Edwards SAPIEN or Medtronic Corevalve transcatheter aortic valve implantation (TAVI): Results of the Belgian TAVI registry (2015) (15)
The impact of left ventricular ejection fraction on fractional flow reserve: Insights from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) trial. (2016) (14)
Pressure–Diameter Relationship in Human Coronary Arteries (2012) (14)
Computed tomographic myocardial mass compared with invasive myocardial perfusion measurement (2020) (14)
Thr164Ile polymorphism of beta2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy. (2007) (14)
FFR in bifurcation stenting: what have we learned? (2010) (14)
Implementing Coronary Computed Tomography Angiography in the Catheterization Laboratory. (2020) (14)
Hydropneumopericardium with tamponade as a late complication of surgical repair of hiatus hernia. (1987) (14)
Standardized Hyperemic Stress for Fractional Flow Reserve (2013) (14)
What can intracoronary pressure measurements tell us about flow reserve? Pressure‐Bounded coronary flow reserve and example application to the randomized DEFER trial (2017) (14)
Compensatory enlargement of the left main coronary artery: insights from the PROSPECT study (2014) (14)
Fractional flow reserve in patients with reduced ejection fraction. (2020) (14)
Influence of transradial versus transfemoral diagnostic heart catheterisation on peripheral vascular endothelial function. (2013) (14)
Clinical Validation of a Virtual Planner for Coronary Interventions Based on Coronary CT Angiography. (2022) (14)
Duration of Hyperemia With Intracoronary Administration of Papaverine (2021) (14)
Long-term serial non-invasive multislice computed tomography angiography with functional evaluation after coronary implantation of a bioresorbable everolimus-eluting scaffold: the ABSORB cohort B MSCT substudy (2017) (14)
Comparison of multivessel coronary angioplasty with surgical revascularization with both internal mammary arteries. (1987) (13)
Synergistic effect of thrombus aspiration and abciximab in primary percutaneous coronary intervention (2013) (13)
Erratum: Practice and potential pitfalls of coronary pressure measurement (2000) (13)
Impact of Pre-Diabetes on Coronary Plaque Composition and Clinical Outcome in Patients With Acute Coronary Syndromes: An Analysis From the PROSPECT Study. (2017) (13)
Thoracoscopic ASD closure is a reliable supplement for percutaneous treatment (2005) (13)
Safety and effectiveness of coronary intravascular lithotripsy in eccentric calcified coronary lesions: a patient-level pooled analysis from the Disrupt CAD I and CAD II Studies (2020) (13)
Monocyte–Platelets Aggregates as Cellular Biomarker of Endothelium-Dependent Coronary Vasomotor Dysfunction in Patients with Coronary Artery Disease (2014) (13)
Evaluation of epicardial coronary resistance using computed tomography angiography: A Proof Concept. (2019) (13)
Risk stratification of coronary plaques using physiologic characteristics by CCTA: Focus on shear stress. (2019) (12)
The immediate and long-term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study. Doppler Endpoints Balloon Angioplasty Trial Europe. (2001) (12)
Low output, low gradient aortic stenosis (2003) (12)
Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention. (2019) (12)
Intracoronary Saline‐Induced Hyperemia During Coronary Thermodilution Measurements of Absolute Coronary Blood Flow: An Animal Mechanistic Study (2020) (12)
A black and white response to the "gray zone" for fractional flow reserve measurements. (2014) (12)
Selective intracoronary hypothermia in patients with ST-elevation myocardial infarction. Rationale and design of the EURO-ICE Trial. (2019) (12)
Routine Pressure Wire Assessment Versus Conventional Angiography in the Management of Patients With Coronary Artery Disease: The RIPCORD 2 Trial (2022) (12)
Intracoronary beta-irradiation for the treatment of de novo lesions: 5-year clinical follow-up of the BetAce randomized trial. (2007) (12)
NT-proANP circulating level is a prognostic marker in stable ischemic heart disease. (2012) (11)
Invasive measures of myocardial perfusion and ischemia. (2015) (11)
Simplified Assessment of the Index of Microvascular Resistance (2021) (11)
Right ventricular pseudoaneurysm as a complication of endomyocardial biopsy after heart transplantation. (1995) (11)
Usefulness of Coronary Atheroma Burden to Predict Cardiovascular Events in Patients Presenting With Acute Coronary Syndromes (from the PROSPECT Study). (2015) (11)
Value of coronary stenotic flow velocity acceleration in prediction of angiographic restenosis following balloon angioplasty. (2002) (11)
Prognostic Factors in Patients With Stemi Undergoing Primary PCI in the Clopidogrel Era: Role of Dual Antiplatelet Therapy at Admission and the Smoking Paradox on Long‐Term Outcome (2017) (10)
Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding After Percutaneous Coronary Intervention via the Femoral Approach: Development and Validation of a New Bleeding Risk Score (2015) (10)
Safety of Selective Intracoronary Hypothermia During Primary Percutaneous Coronary Intervention in Patients With Anterior STEMI. (2021) (10)
Myotomy through heart-port access for myocardial bridging. (2008) (10)
Usefulness of Beta2-Microglobulin as a Predictor of All-Cause and Nonculprit Lesion-Related Cardiovascular Events in Acute Coronary Syndromes (from the PROSPECT Study). (2015) (10)
Instantaneous wave-free ratio or fractional flow reserve without hyperemia: novelty or nonsense? (2012) (10)
Rationale and design of the Flow Evaluation to Guide Revascularization in Multivessel ST-Elevation Myocardial Infarction (FLOWER-MI) trial. (2019) (9)
Rationale and design of the precise percutaneous coronary intervention plan (P3) study: Prospective evaluation of a virtual computed tomography‐based percutaneous intervention planner (2021) (9)
Relation of C-reactive protein levels to instability of untreated vulnerable coronary plaques (from the PROSPECT Study). (2014) (9)
Quantitative assessment of the coronary microvasculature: new tools for the black box. (2013) (9)
Quantification of calcium burden by coronary CT angiography compared to optical coherence tomography (2020) (9)
Risk of myocardial infarction based on endothelial shear stress analysis using coronary angiography. (2021) (9)
4-Year outcome of bioactive stents versus everolimus-eluting stents in acute coronary syndrome (2016) (8)
Comparison among patients≥75 years having percutaneous coronary angioplasty using drug-eluting stents versus bare metal stents. (2015) (8)
How should I treat a patient with refractory angina and a single stenosis with normal FFR but abnormal CFR? (2015) (8)
A protocol update of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 trial: A comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease. (2019) (8)
Changes in infarct size and left ventricular ejection fraction: new prognostic factors after acute myocardial infarction? (2007) (8)
Drug-eluting stent implantation: technique matters, more than ever. (2008) (8)
Fractional flow reserve-guided PCI. (2015) (8)
Sex Differences in Adenosine-Free Coronary Pressure Indexes: A CONTRAST Substudy. (2018) (8)
Relationship between insulin resistance, coronary plaque, and clinical outcomes in patients with acute coronary syndromes: an analysis from the PROSPECT study (2021) (7)
Coronary lesion progression as assessed by fractional flow reserve (FFR) and angiography. (2018) (7)
Trans-lesional fractional flow reserve gradient as derived from coronary CT improves patient management: ADVANCE registry☆ (2021) (7)
Tissue Doppler predicts long-term clinical outcome after cardiac resynchronization therapy. (2008) (7)
Autoregulation of Coronary Blood Supply in Response to Demand: JACC Review Topic of the Week. (2021) (7)
Instantaneous Wave-free Ratio versus Fractional Flow Reserve. (2017) (7)
Does clinical presentation affect outcome among patients with acute coronary syndromes undergoing percutaneous coronary intervention? Insights from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study. (2012) (7)
Long-Term Patency of Coronary Artery Bypass Grafts After Fractional Flow Reserve-Guided Implantation. (2019) (6)
Influence of Contrast Media Dose and Osmolality on the Diagnostic Performance of Contrast Fractional Flow Reserve (2017) (6)
Hyperemic hemodynamic characteristics of serial coronary lesions assessed by pullback pressure gradients (2021) (6)
Optimizing Revascularization Strategies in Coronary Artery Disease for Optimal Benefit to Patients (2011) (6)
Coronary Microcirculation in Aortic Stenosis: Pathophysiology, Invasive Assessment, and Future Directions (2020) (6)
Percutaneous transluminal coronary angioplasty of the left coronary artery in patients with chronic occlusion of the right coronary artery: clinical and functional results. (1991) (6)
Asymptomatic Patients With Abnormal Fractional Flow Reserve Treated With Medication Alone or With PCI. (2019) (6)
Influence of fractional flow reserve on grafts patency: Systematic review and patient‐level meta‐analysis (2021) (6)
Fractional flow reserve in acute coronary syndromes. (2015) (6)
Coronary Autoregulatory Plateau in Humans. (2020) (5)
The Shifting Sands of Coronary Microvascular Dysfunction. (2019) (5)
Diagnostic Performance of Angiography-based Fractional Flow Reserve in Various Subgroups: Report from the FAST-FFR Study. (2020) (5)
Angiography and fractional flow reserve in daily practice: why not (finally) use the right tools for decision-making? (2013) (5)
Absolute coronary flow and microvascular resistance reserve in patients with severe aortic stenosis (2022) (5)
Angiographic, intravascular ultrasound, and fractional flow reserve evaluation of direct stenting vs. conventional stenting using BeStent2 in a multicentre randomized trial. (2005) (5)
Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries. (2004) (5)
Lumen Measurements From Quantitative Coronary Angiography and IVUS: A PROSPECT Substudy. (2016) (5)
Saline-induced coronary hyperemia with continuous intracoronary thermodilution is mediated by intravascular hemolysis. (2022) (5)
Graft patency and progression of coronary artery disease after CABG assessed by angiography-derived fractional flow reserve. (2020) (5)
Response to letter regarding article, "revascularization decisions in patients with stable angina and intermediate lesions: results of the international survey on interventional strategy". (2015) (4)
Global Fractional Flow Reserve Value Predicts 5‐Year Outcomes in Patients With Coronary Atherosclerosis But Without Ischemia (2020) (4)
Accurate assessment of coronary blood flow by continuous thermodilution technique: Validation in a swine model (2021) (4)
Effect of Prior Aspirin Treatment on Patients With Acute Coronary Syndromes: Insights From the PROSPECT Study. (2015) (4)
The clinical utility of FFRCT stratified by age. (2020) (4)
Functional assessment of coronary atherosclerosis in the catheterization laboratory: the key role of fractional flow reserve. (2005) (4)
Differential Improvement in Angina and Health-Related Quality of Life After PCI in Focal and Diffuse Coronary Artery Disease. (2022) (4)
Angiography-Derived Fractional Flow Reserve Versus Invasive Nonhyperemic Pressure Ratios. (2019) (4)
Phasic pressure measurements for coronary and valvular interventions using fluid‐filled catheters: Errors, automated correction, and clinical implications (2020) (4)
Relationship between left main coronary artery plaque burden and nonleft main coronary atherosclerosis: results from the PROSPECT study (2018) (4)
Qualitative resting coronary pressure wave form analysis to predict fractional flow reserve. (2019) (4)
Macrophage migration inhibitory factor (MIF) is associated with degree of collateralization in patients with totally occluded coronary arteries. (2018) (4)
Diagnostic performance of angiography-based fractional flow reserve by patient and lesion characteristics (2021) (4)
Risk and timing of clinical events according to diabetic status of patients treated with everolimus‐eluting bioresorbable vascular scaffolds versus everolimus‐eluting stent: 2‐year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials (2018) (4)
Clinical Outcome of Patients with Aortic Stenosis and Coronary Artery Disease Not Treated According to Current Recommendations (2016) (4)
Relationship between peripheral arterial reactive hyperemia and the index of myocardial resistance in patients undergoing invasive coronary angiography. (2021) (4)
Biomarkers of vulnerable plaque: the missing link with ischemia. (2010) (4)
Ability of FFR-CT to detect the absence of hemodynamically significant lesions in patients with high-risk NSTE-ACS admitted in the emergency department with chest pain, study design and rationale (2020) (4)
Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients (2020) (4)
Coronary Artery Bypass Grafting or Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Diabetic Patients With Multivessel Disease (2020) (4)
Effective radiation doses associated with non‐invasive versus invasive assessment of coronary anatomy and physiology (2015) (4)
Twelve-month clinical and imaging outcomes of the uncaging DynamX Bioadaptor System. (2020) (4)
Contemporary Management of Stable Coronary Artery Disease (2022) (3)
Prospective evaluation of the learning curve and diagnostic accuracy for Pre-TAVI cardiac computed tomography analysis by cardiologists in training: The LEARN-CT study. (2022) (3)
Intracoronary beta-irradiation prevents excessive in-stent neointimal proliferation in de novo lesions of patients with high plasma ACE levels. The BetAce randomized trial. (2005) (3)
Development, validation, and reproducibility of the pullback pressure gradient (PPG) derived from manual fractional flow reserve pullbacks (2022) (3)
Temporal changes in FFRCT-Guided Management of Coronary Artery Disease - Lessons from the ADVANCE Registry. (2020) (3)
Dopamine‐induced changes in renal blood flow in normals and in patients with renal dysfunction (2008) (3)
Accordion phenomenon induced by pressure wire. (2011) (3)
Motorized fractional flow reserve pullback: Accuracy and reproducibility (2020) (3)
The reconciliation of pressure and light: a clinical case of complementary use of fractional flow reserve and optical coherence tomography. (2011) (3)
Validation of Coronary Angiography-Derived Vessel Fractional Flow Reserve in Heart Transplant Patients with Suspected Graft Vasculopathy (2021) (3)
Multivessel disease: from reasonably incomplete to functionally complete revascularization. (2012) (3)
Prognostic Implications of Fractional Flow Reserve After Coronary Stenting (2022) (3)
Real-Life Fractional Flow Reserve (2017) (3)
The WOEST 2 registry (2022) (2)
A Meta-Analysis of Recent Trials Comparing Revascularization With Medical Therapy Alone in Patients With Chronic Coronary Syndrome. (2021) (2)
Coronary volume to left ventricular mass ratio in patients with diabetes mellitus. (2022) (2)
10-Year Survival After FFR-Guided Strategy in Isolated Proximal Left Anterior Descending Coronary Stenosis. (2019) (2)
Dynamic left ventricular outflow tract obstruction as a potential mechanism of myocardial rupture after acute myocardial infarction. (1999) (2)
Diagnostic performance of exercise stress tests for detection of epicardial and microvascular coronary artery disease: the UZ Clear study. (2022) (2)
Physiological and angiographic outcomes of PCI in calcified lesions after rotational atherectomy or intravascular lithotripsy. (2022) (2)
Hyperemic Pressure-Flow Relationship in a Human. (2019) (2)
Mismatch between morphological and functional assessment of the length of coronary artery disease. (2021) (2)
Response to letter regarding article, "fractional flow reserve assessment of left main stenosis in the presence of downstream coronary stenoses". (2013) (2)
Percutaneous Transfemoral TAVR With Direct Puncture and Successful Closure of Aortobifemoral Bypass Graft (2019) (2)
Coronary computed tomography angiography: CONFIRMations and perspectives. (2011) (2)
Automation of intracoronary continuous thermodilution for absolute coronary flow and microvascular resistance measurements (2022) (2)
Safety of Right and Left Ventricular Endomyocardial Biopsy in Heart Transplantation and Cardiomyopathy Patients. (2022) (2)
Apical hypertrophic cardiomyopathy of the "Japanese type" in Western countries. (1987) (2)
Procedural Outcomes After Percutaneous Coronary Interventions in Focal and Diffuse Coronary Artery Disease (2022) (2)
The 'napkin-ring' constrictive pericarditis. (2016) (2)
Aortic valve replacement improves survival in severe aortic stenosis with gradient–area mismatch (2018) (2)
Prognostic role of multiple biomarkers in stable patients undergoing fractional flow reserve-guided coronary angioplasty (2016) (2)
Unrecognized anomalous left circumflex coronary artery arising from right sinus of Valsalva: a source of perioperative complication. (2016) (2)
Deep learning-based prediction of future myocardial infarction using invasive coronary angiography: a feasibility study (2023) (1)
When "Slow Flow" Is Not "Low Flow". (2022) (1)
Absolute Blood Flow in the Left Main Coronary Artery and Its Distribution. (2021) (1)
Changes in surgical revascularization strategy after fractional flow reserve (2021) (1)
From debulking to delivery: sequential use of rotational atherectomy and Guidezilla™ for complex saphenous vein grafts intervention (2018) (1)
DISENGAGE Registry (2020) (1)
TCT-346 Safety of Right and Left Ventricular Endomyocardial Biopsy in Heart Transplant and Cardiomyopathy Patients (2022) (1)
Coronary flow velocity reserve and survival. (2012) (1)
BWGIC guidelines for training and quality control in adult interventional cardiology. Belgian Working Group of Invasive Cardiology. (1997) (1)
Response by Fearon et al to Letter Regarding Article, "Accuracy of Fractional Flow Reserve Derived From Coronary Angiography". (2019) (1)
FFR or OCT or FFR and OCT. (2020) (1)
Significance of prior percutaneous revascularisation in patients with acute coronary syndromes: insights from the prospective PROSPECT registry. (2016) (1)
[Current concepts of the physiopathology of coronary beta-adrenergic receptors, and their clinical applications]. (2005) (1)
Response by Piroth et al to Letter Regarding Article, "Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation". (2017) (1)
Impact of non-invasive anatomical testing on optimal medical prescription in patients with suspected coronary artery disease. (2019) (1)
Acute coronary syndromes in patients with multivessel disease: the key role of optical coherence tomography. (2016) (1)
Right ventricular myocardial infarction (2005) (1)
Assessment of absolute coronary flow and microvascular resistance reserve in patients with severe aortic stenosis (2022) (1)
Highlights of the 2006 scientific sessions of the European Society of Cardiology: Barcelona, Spain, September 2-5, 2006. (2006) (1)
Quality of Life After Fractional Flow Reserve–Guided PCI Compared With Coronary Bypass Surgery (2022) (1)
Comparative study of neointimal coverage between titanium-nitric oxide-coated and everolimus-eluting stents in acute coronary syndromes. (2022) (1)
Future culprit detection based on angiography‐derived FFR (2021) (1)
Impact of Intravascular Ultrasound–Derived Lesion-Specific Virtual Fractional Flow Reserve Predicts 3-Year Outcomes of Untreated Nonculprit Lesions: The PROSPECT Study (2022) (1)
Diagnostic performance of angiography‐derived fractional flow reserve in patients with NSTEMI (2022) (1)
A novel approach to assess cerebral and coronary perfusion after cardiac arrest (2018) (1)
Value of coronary stenotic flow velocity acceleration on the prediction of long-term improvement in functional status after angioplasty. (2001) (1)
Humoral and echo-Doppler parameters in predicting the benefits of betablockers in patients with dilated cardiomyopathy. (2001) (0)
[Intermediate lesion and multivessels disease: Interest of fractional flow reserve (FFR) to determine the strategy of revascularization]. (2011) (0)
TCT-170 Angiography- Versus FFR-Based Deferral of Revascularization in Patients With Reduced Ejection Fraction: 10-Year Follow-Up Study (2021) (0)
TCT-399 Relationship Between Coronary CT Angiography–Derived Fractional Flow Reserve and Clinical Outcomes in Patients With and Without Diabetes (2021) (0)
TCT-236 Accuracy of the FFRCT Planner in Coronary Calcific Lesions (2022) (0)
Corrigendum to ’ Same Day Discharge Strategy by Default in a Tertiary Catheterization Laboratory. Value Based Healthcare-Change in Practice.’ [Health Policy, Volume 132, June 2023, 104826, ISSN 0168-8510] (2023) (0)
Resolving Apparent Inconsistencies Between Area, Flow, and Gradient Measurements in Patients With Aortic Valve Stenosis and Preserved Left Ventricular Ejection Fraction. (2017) (0)
TCT-157 A Novel “Uncaging” DynamX Bioadaptor Restores Vascular Pulsatility, Vasomotion and Adaptive Remodelling: Final 36-Month Clinical Results and 12-Month Imaging Data (2022) (0)
Repeatability of bolus and continuous thermodilution for assessing coronary microvasculatory function (2022) (0)
TCT-348 Physiological and Angiographic Outcomes of PCI in Calcified Lesions After Rotational Atherectomy or Intravascular Lithotripsy (2021) (0)
TCT-258 Relationship Between Myocardial Mass and Post-PCI Fractional Flow Reserve (2021) (0)
[Change in indications for coronary angiography in a decade]. (1987) (0)
Use of a pressure wire for automatically correcting artifacts in phasic pressure tracings from a fluid-filled catheter. (2022) (0)
Coronary-Artery Bypass Grafting. (2016) (0)
Virtual Fractional Flow Reserve in Heart Transplant Recipients with and without Graft Vasculopathy. (2020) (0)
Reliability Safety of a Side-Branch Jailed Second-Generation Optical-Pressure Guidewire in Physiology-Guided Bifurcation-PCI In Vitro Model. (2022) (0)
TCT-273 Relationship Between Coronary Volume, Myocardial Mass and Post-PCI Fractional Flow Reserve (2022) (0)
Anatomic and functional discordance among patients with non-obstructive coronary disease (2022) (0)
Deep Learning For Prediction of Fractional Flow Reserve From Resting Coronary Pressure Curves (ARTIST study). (2020) (0)
Wall Shear Stress Topological Skeleton Variability Predicts Myocardial Infarction (2022) (0)
TCT-487 DynamX Bioadaptor, a Novel “Uncaging” Platform for Coronary Artery Revascularization: Final 36-Month Clinical Results (2021) (0)
Relationship between coronary volume, myocardial mass, and post-PCI fractional flow reserve. (2023) (0)
Microvascular dysfunction in patients with diabetes mellitus: assessment of absolute coronary flow and microvascular resistance reserve (2022) (0)
Computed tomography coronary angiography, percutaneous coronary intervention, and (S)low flow. (2012) (0)
Improvement in angina pectoris after percutaneous coronary interventions in focal and diffuse coronary artery disease (2022) (0)
723 PREDICTORS OF PERCUTANEOUS CORONARY INTERVENTION DERIVED FROM CORONARY CT ANGIOGRAPHY IN PATIENTS WITH CHRONIC CORONARY SYNDROME (2022) (0)
452 Saline-induced coronary hyperaemia is mediated by intravascular haemolysis (2021) (0)
TCT-297 Prevalence of Coronary Microvascular Disease in Patients With Non-Obstructive Coronary Artery Disease (2022) (0)
TCT-198 Differential Improvement in Angina and Health-Related Quality of Life After Percutaneous Coronary Interventions in Focal and Diffuse Coronary Artery Disease (2022) (0)
Prognostic Value of Measuring Fractional Flow Reserve After Percutaneous Coronary Intervention in Patients With Complex Coronary Artery Disease: Insights From the FAME 3 Trial (2022) (0)
Conversation in cardiology: Should FFR and IVUS be counted as PCI? (2013) (0)
[Intracoronary pressure and its significance in the clinical evaluation of patients with ischemic heart disease]. (1996) (0)
[Fractional flow reserve to establish the indication for and guide myocardial revascularization]. (2017) (0)
TCT-537 What can intracoronary pressure measurements tell us about flow reserve? Pressure-bounded CFR and its application to the randomized DEFER trial. (2016) (0)
437 Accuracy Of The FFRCTPlanner In Coronary Calcific Lesions (2022) (0)
TCT-520 Qualitative Resting Wave Form Analysis to Predict an Abnormal Fractional Flow Reserve (FFR): A CONTRAST FFR Sub-Study. (2016) (0)
Influence of Target Vessel on Post-PCI iFR. (2022) (0)
Impact of Functional Severity of Coronary Artery Disease on Arterial Versus Venous Graft Patency. (2022) (0)
TCT-557 Impact of the Extent of Circumferential Plaque on Non-Culprit Lesion-Related Events: A PROSPECT Substudy. (2016) (0)
DIFFERENTIAL PATTERNS OF ATHEROSCLEROSIS IN PATIENTS WITH FOCAL AND DIFFUSE CORONARY ARTERY DISEASE (2023) (0)
TCT-548 Relationship Between Residual SYNTAX Score, Grayscale and Virtual Histology-IVUS Findings, and Non-Culprit Lesion-Related Major Adverse Cardiac Events: The PROSPECT Study. (2016) (0)
TCT-86 Anatomic and Functional Discordance Among Patients With Nonobstructive Coronary Disease (2021) (0)
[Percutaneous coronary angioplasty in unstable angina and acute infarction]. (1987) (0)
389 Microvascular dysfunction in patients with Type II diabetes mellitus: invasive assessment of absolute coronary blood flow and microvascular resistance reserve (2021) (0)
PROcedure related microvascular ACTIVation in long lEsions treated with bioresorbable vascular scaffold versus everolimus-eluting stent implantation (PROACTIVE trial). (2020) (0)
PCI Guided by Fractional Flow Reserve at 5 Years. (2019) (0)
Response to letter regarding article, "Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve". (2014) (0)
Stenting for renal-artery stenosis. (2014) (0)
Reply (2020) (0)
TCT-232 Head-to-Head Comparison of Two Different Angiography-Derived FFR Techniques in NSTEMI Patients (2022) (0)
TCT-94 Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically Treated Patients With Diabetes Mellitus: Insights From the PROSPECT Study. (2016) (0)
First report of totally robotically assisted hybrid coronary artery revascularization combining RE‐MIDCAB and R‐PCI: Case report (2022) (0)
840 ASSESSMENT OF ABSOLUTE CORONARY FLOW AND MICROVASCULAR RESISTANCE RESERVE IN PATIENTS WITH AORTIC STENOSIS (2022) (0)
Reply: True Fractional Flow Reserve of Left Main Coronary Artery Stenosis in the Presence of Downstream Coronary Stenoses. (2015) (0)
Renal V-stenting. (2007) (0)
TCT-229 Impact of Coronary CT Image Quality on the Accuracy of the FFRCT Planner to Predict Fractional Flow Reserve After PCI (2021) (0)
Same Day Discharge Strategy by Default in a Tertiary Catheterization Laboratory. Value Based Healthcare-Change in Practice. (2023) (0)
451 Deferral of coronary revascularization in patients with reduced ejection fraction based on physiological assessment: impact on long-term survival (2021) (0)
Impact of the Extent of Circumferential Plaque on Nonculprit Lesion-Related Events: A PROSPECT Substudy. (2019) (0)
742 PROGNOSTIC IMPACT OF HIGH BLEEDING RISK IN PATIENTS WITH CALCIFIED CORONARY ARTERY DISEASE UNDERGOING ROTATIONAL ATHERECTOMY PCI (2022) (0)
Quantification of valvular regurgitation by cardiac blood pool scintigraphy: correlation with catheterization. (1987) (0)
Deferral of Coronary Revascularization in Patients With Reduced Ejection Fraction Based on Physiological Assessment: Impact on Long‐Term Survival (2022) (0)
TCT-303 The Influence of Obesity on Coronary Artery Disease and Clinical Outcomes in the ADVANCE Registry (2021) (0)
851 REPEATABILITY OF BOLUS AND CONTINUOUS THERMODILUTION FOR ASSESSING CORONARY MICROVASCULAR FUNCTION (2022) (0)
TCT-358 Accuracy of the FFRCT Planner in Coronary Calcific Lesions: A Substudy of the Precise PCI Plan (P3) Study (2021) (0)
TCT-278 Accuracy of Luminal Sizing Using Coronary Computed Tomography Angiography as Compared With Optical Coherence Tomography Prior to Percutaneous Coronary Intervention (2022) (0)
Reply: The Randomized TIDES-ACS Trial. (2020) (0)
[Determination of pulmonary capillary wedge pressure by M-mode echocardiography]. (1985) (0)
Steady-state hyperaemia: many routes, one goal. (2020) (0)
Reproducibility of bolus versus continuous thermodilution for assessment of coronary microvascular function in patients with ANOCA. (2023) (0)
Ephemeral coronary lesion after epicardial RF ablation for premature ventricular contractions (2019) (0)
VASCULAR REMODELING IN CORONARY MICROVASCULAR DYSFUNCTION (2023) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Bernard De Bruyne?

Bernard De Bruyne is affiliated with the following schools:

Vilnius University
Vanderbilt University
Stanford University
Eindhoven University of Technology
University of Naples Federico II
Tokyo Medical University
Columbia University
University of Crete
Maastricht University
Erasmus University Rotterdam
Sorbonne University
Medical University of Graz
University of Lausanne